FEV1 response to bronchodilation in an adult urban population

Chest

Volumn 134, Issue 2, 2008, Pages 387-393

  Kainu, Annette ^a   Lindqvist, Ari ^a   Sarna, Seppo ^b   Lundbäck, Bo ^c   Sovijärvi, Anssi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bronchodilation; FEV1; Flow volume spirometry; Lung function

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AEROSOL; AGED; ARTICLE; BRONCHODILATATION; CIGARETTE SMOKING; CONTROLLED STUDY; DEVICE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; STRUCTURED INTERVIEW; URBAN POPULATION; BODY SIZE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FINLAND; HEALTH; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING; VITAL CAPACITY;

ADULT; AGED; ALBUTEROL; BODY SIZE; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; FINLAND; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; SMOKING; SPIROMETRY; URBAN HEALTH; VITAL CAPACITY;

EID: 49449117775     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-2207     Document Type: Article

References (29)

1. Nicklaus TM, Burgin WW, Taylor JR. Spirometric tests to diagnose suspected asthma. Am Rev Respir Dis 1969; 100:153-159
2. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
3. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
4. American Thoracic Society. Standardisation of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
5. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal; official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40
6. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42:487-490
7. 1. Eur Respir J 1992; 5:975-981
8. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease: the Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47:429-436
9. Calverley PMA, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664
10. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60:842-847
11. Anthonisen NR, Lindgren PG, Tashkin DP, et al. Bronchodilator response in the Lung Health Study over 11 years. Eur Respir J 2005; 26:45-51
12. Weir DC, Burge PS. Measures of reversibility in response to bronchodilator in chronic airflow obstruction: relation to airway calibre. Thorax 1991; 46:43-45
13. Lorber DB, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978; 118:855-861
14. 2-agonist. Pulm Pharm Ther 2006; 19:272-280
15. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173:1316-1325
16. Dales RE, Spitzer WO, Tousignant P, et al. Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations. Am Rev Respir Dis 1988; 138:317-320
17. Meslier N, Racineux JL, Six P, et al. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach. Eur Respir J 1989; 2:497-505
18. Pride NB. Tests of forced expiration and inspiration. Clin Chest Med 2001; 22:599-622
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338
20. Lindström M, Kotaniemi J, Jönsson E, et al. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest 2001; 119:852-861
21. Pallasaho P, Rönmark E, Haahtela T, et al. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy 2006; 36:503-509
22. Meren M, Jannus-Pruljan L, Loit H-M, et al. Asthma, chronic bronchitis and respiratory symptoms among adults in Estonia according to a postal questionnaire. Respir Med 2001; 95:954-964
23. Lundbäck B. Asthma, chronic bronchitis and respiratory symptoms: prevalence and important determinants; the Obstructive Lung Disease in Northern Sweden Study I. PhD Dissertation, Umeå University, 1993
24. Viljanen AA, Halttunen PK, Kreus K-E, et al. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982; 42:5-20
25. Enright PL, Beck KC, Sherrill DL. Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med 2004; 169:235-238
26. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis 1991; 143:516-521
27. Goedhart DM, Zanen P. Selecting the best method to evaluate bronchodilation when analysing bronchodilator studies. Stat Med 2002; 23:3677-3685
28. Goedhart DM, Zanen P, Lammers J-WJ. Analysing bronchodilation with emphasis on disease type, age and sex. Control Clin Trials 2004; 25:563-571
29. Tashkin DP, Detels R, Simmons M, et al. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994; 149:1209-1217